Michael Scolaro

Michael Scolaro

Nov 16, 2017

Group 6 Copy 196
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection

    We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...

    Gila monster genomics: conservation, venom, and treatments for Type-II diabetes

    The Gila monster, with its distinctive black and orange pattern, is one of Arizona’s most iconic animals...

    Can we noninvasively measure blood sugar for diabetes?

    Better management of type 1 diabetes is moving towards anartificial pancreas. However, we need a better...

    Backer Badge Funded